Gossamer Bio Inc. (GOSS) Misses Q4 EPS by 2c, Beats on Revenue

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q4 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $7.52 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Gossamer Bio Inc. (GOSS) PT Lowered to $2 at H.C. Wainwright
• AES stockholders approve $10.7 billion takeover by GIP and EQT
• Deutsche Bank Upgrades Softbank Group Corp. (9984:JP) (SFTBY) to Buy